Donate today and help support research into early diagnosis

Give once
Give monthly

Donate £25

Could help our clinicians conduct more life-saving research into early diagnosis and provide hope for years to come.

Donate £75

Could support early diagnosis tools, like liquid biopsies, that will speed up diagnosis and save more lives.

Donate £150

Could fund state-of-the-art equipment that provides patients with a faster and more accurate diagnosis.

Donate £5

Could help continue our world-leading cancer research and change how cancer is treated forever.

Donate £10

Could help The Royal Marsden continue its pursuit of improving and saving lives of more people affected by cancer.

Donate £15

Could allow our doctors, nurses, and researchers to drive forward advances in patient care.

A Doctor, Dr Richard Lee, standing in a hospital room. He is wearing a white shirt and a stethoscope. He has a hopeful smile.

"Finding ways to detect and diagnose cancer earlier will save thousands of lives each year. With your help, we hope to push boundaries to speed up the detection of cancer using the latest technology."

- Dr Richard Lee, Consultant Respiratory Physician & Champion for Early Diagnosis, at The Royal Marsden

Early diagnosis can save lives.

Your donation could support our clinicians to make more breakthroughs in early diagnosis research.

Donate today

Principal investigator of the TRAK-ER trial, Professor Nicholas Turner. He has brown hair, black rimmed glasses on and is smiling.

Leading the way on liquid biopsies at The Royal Marsden

Over the past five years, The Royal Marsden has been leading the way in liquid biopsy research, most notably in breast cancer patients. A liquid biopsy is a type of blood test, and can often detect cancer months, or even years, before a tumour becomes visible on a scan or a patient develops symptoms. This can truly be life-changing.

One of our current trials, the TRAK-ER trial, is studying whether liquid biopsies can identify if Estrogen receptor (ER) positive breast cancer has come back before it is visible on a scan.

“If the trial produces encouraging results, this could revolutionise how we treat ER positive breast cancer patients in the future and hopefully save more lives.”

- Professor Nicholas Turner. Chief Investigator of the TRAK-ER trial

A woman, Natalie, smiling at the camera and resting her head in her hand. She has dark hair and eyes, and is sat on a pink char and is wearing a blue dress.

"It felt like the first day I could start the next chapter of my life."

Natalie, 47, was diagnosed with breast cancer in 2019. She is the mum to two daughters, a dance teacher, and a keen runner.

“When I got the call to say I might be eligible to join the TRAK-ER trial, I called my mum and was shaking with excitement! Being part of something that could prevent me getting secondary breast cancer is reassuring. It’s an incredibly positive step forward for the next generation.”

“I have been incredibly fortunate to have my first result back since joining the TRAK-ER trial, a life changing result of negative. It felt like the first day I could start the next chapter of my life. I felt like a huge weight had lifted. I felt free – free from the cancer."

Help us ensure early diagnosis becomes a reality for more people.

Your support could make more life-saving research trials possible for patients like Natalie.

Donate now

Give once